Literature DB >> 3903748

Synthesis and secretion of human epidermal growth factor by Escherichia coli.

T Oka, S Sakamoto, K Miyoshi, T Fuwa, K Yoda, M Yamasaki, G Tamura, T Miyake.   

Abstract

A synthetic gene for human epidermal growth factor (hEGF) was joined to a sequence encoding the signal peptide of Escherichia coli alkaline phosphatase. This hybrid gene was placed under the control of the alkaline phosphatase gene (phoA) promoter in a recombinant plasmid, which was used to transfect E. coli. The hybrid protein that was expressed in host cells under conditions of phosphate limitation was processed accurately during the secretion process, and mature hEGF was recovered in the periplasmic fraction. On the other hand, no EGF was detected in the periplasmic space when the synthetic hEGF gene was not accompanied by the phoA signal sequence.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903748      PMCID: PMC390819          DOI: 10.1073/pnas.82.21.7212

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Effect of urogastrone on gastric secretion and plasma gastrin levels in normal subjects.

Authors:  J B Elder; P C Ganguli; I E Gillespie; E L Gerring; H Gregory
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

2.  Isolation and structure of urogastrone and its relationship to epidermal growth factor.

Authors:  H Gregory
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

3.  A fine-structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterization of alkaline phosphatase.

Authors:  A GAREN; C LEVINTHAL
Journal:  Biochim Biophys Acta       Date:  1960-03-11

Review 4.  The assembly of proteins into biological membranes: The membrane trigger hypothesis.

Authors:  W Wickner
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

5.  Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro.

Authors:  G Carpenter; L King; S Cohen
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

6.  The release of enzymes from Escherichia coli by osmotic shock and during the formation of spheroplasts.

Authors:  H C Neu; L A Heppel
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

7.  Synthesis and processing of an Escherichia coli alkaline phosphatase precursor in vitro.

Authors:  H Inouye; J Beckwith
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

8.  Effect of urogastrone in the Zollinger-Ellison syndrome.

Authors:  J B Elder; I E Gillespie; P C Ganguli; W I Delamore; H Gregory
Journal:  Lancet       Date:  1975-09-06       Impact factor: 79.321

9.  Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin.

Authors:  K Itakura; T Hirose; R Crea; A D Riggs; H L Heyneker; F Bolivar; H W Boyer
Journal:  Science       Date:  1977-12-09       Impact factor: 47.728

10.  Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.

Authors:  G Blobel; B Dobberstein
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

View more
  31 in total

Review 1.  Growth factors in the gastrointestinal tract.

Authors:  N R Lemoine; H Y Leung; W J Gullick
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

2.  High level expression in Escherichia coli of soluble, enzymatically active schistosomal hypoxanthine/guanine phosphoribosyltransferase and trypanosomal ornithine decarboxylase.

Authors:  S P Craig; L Yuan; D A Kuntz; J H McKerrow; C C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 3.  High-expression of a target gene and high-stability of the plasmid.

Authors:  M Kobayashi; Y Kurusu; H Yukawa
Journal:  Appl Biochem Biotechnol       Date:  1991-02       Impact factor: 2.926

4.  Proton nuclear magnetic resonance study on the solution conformation of human epidermal growth factor.

Authors:  K Makino; M Morimoto; M Nishi; S Sakamoto; A Tamura; H Inooka; K Akasaka
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Immunohistochemical distribution of human epidermal growth factor in salivary gland tumours.

Authors:  M Mori; R Naito; K Tsukitani; Y Okada; T Hayashi; K Kato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  Phosphorylation in the carboxyl-terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibody.

Authors:  A Machida; H Ohnuma; F Tsuda; A Yoshikawa; Y Hoshi; T Tanaka; S Kishimoto; Y Akahane; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Use of Bacillus brevis for efficient synthesis and secretion of human epidermal growth factor.

Authors:  H Yamagata; K Nakahama; Y Suzuki; A Kakinuma; N Tsukagoshi; S Udaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Localization of epidermal growth factor (EGF) binding sites on antiluminal plasma membrane of rat kidney: autoradiographic study using nonfiltering perfused rat kidney.

Authors:  D C Kim; Y Sugiyama; Y Kanai; N Ohnuma; M Hanano
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

9.  Expression line approach to recombinant human epidermal growth factor into the yeast, Pichia pastoris from Huh-7 cell line.

Authors:  Mohsin Ahmad Khan; Faidad Khan; Nadeem Ahmad; Muhammad Islam Khan; Ahmad Usman Zafar; Tayyab Husnain
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

Review 10.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.